Table 4.
HR | 95% CI | P Value | |
---|---|---|---|
Aspirin: yes vs no | 0.77 | 0.6–0.98 | 0.033 |
β‐Blocker: yes vs no | 0.64 | 0.51–0.81 | 0.0002 |
Statin: yes vs no | 0.82 | 0.62–1.10 | 0.18 |
Catheter‐based revascularization: yes vs no | 0.57 | 0.29–1.10 | 0.09 |
Age, y | 1.01 | 1.00–1.02 | 0.07 |
Cancer: lymphoma/leukemia vs solid tumors | 1.19 | 0.94–1.51 | 0.15 |
Cancer status: advanced vs limited | 2.12 | 1.47–3.04 | <0.0001 |
Hyperlipidemiaa | 0.73 | 0.56–0.95 | 0.018 |
Previous chemotherapya | 1.42 | 1.11–1.81 | 0.005 |
Chest radiotherapya | 1.40 | 1.06–1.84 | 0.017 |
Abbreviations: CI, confidence interval; HR, hazard ratio.
Compared with no history.